The rare biomarkers market, which was worth USD 55.59 billion in 2022, is projected to grow to USD 154.19 billion, with a CAGR of 13.6% over the forecast by 2030.

The biomarkers market, which was worth USD 43.13 million in 2022, is predicted to grow to USD 153.34 million by 2030, with a CAGR of 14.90% in the forecast period.